| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.093 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |